These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37166074)

  • 1. Advancements in the pharmacological management of sepsis in the elderly.
    Psarrakis C; Giamarellos-Bourboulis EJ
    Expert Opin Pharmacother; 2023; 24(10):1171-1187. PubMed ID: 37166074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
    Rello J; van Engelen TSR; Alp E; Calandra T; Cattoir V; Kern WV; Netea MG; Nseir S; Opal SM; van de Veerdonk FL; Wilcox MH; Wiersinga WJ
    Clin Microbiol Infect; 2018 Dec; 24(12):1264-1272. PubMed ID: 29581049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing sepsis in the era of precision medicine: challenges and opportunities.
    Watkins RR; Bonomo RA; Rello J
    Expert Rev Anti Infect Ther; 2022 Jun; 20(6):871-880. PubMed ID: 35133228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis.
    Iankova I; Thompson-Leduc P; Kirson NY; Rice B; Hey J; Krause A; Schonfeld SA; DeBrase CR; Bozzette S; Schuetz P
    Crit Care Med; 2018 May; 46(5):691-698. PubMed ID: 29271844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of pediatric patients with sepsis.
    Simmons ML; Durham SH; Carter CW
    AACN Adv Crit Care; 2012; 23(4):437-48; quiz 449-50. PubMed ID: 23095969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging infection and sepsis biomarkers: will they change current therapies?
    Jacobs L; Wong HR
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):929-41. PubMed ID: 27533847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in sepsis: can they help improve patient outcome?
    Kyriazopoulou E; Poulakou G; Giamarellos-Bourboulis EJ
    Curr Opin Infect Dis; 2021 Apr; 34(2):126-134. PubMed ID: 33534419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for the treatment of sepsis.
    Heming N; Lamothe L; Ambrosi X; Annane D
    Expert Opin Emerg Drugs; 2016; 21(1):27-37. PubMed ID: 26751198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs in sepsis.
    Leone M; Textoris J; Michel F; Wiramus S; Martin C
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):41-52. PubMed ID: 20055688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.
    Wang J; Zhang H; Yan J; Zhang T
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):861-870. PubMed ID: 32102584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic regimens for late-onset neonatal sepsis.
    Korang SK; Safi S; Nava C; Greisen G; Gupta M; Lausten-Thomsen U; Jakobsen JC
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013836. PubMed ID: 33998665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized antibiotic therapy in the treatment of severe infections.
    Annoni F; Grimaldi D; Taccone FS
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):27-35. PubMed ID: 31755789
    [No Abstract]   [Full Text] [Related]  

  • 18. Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?
    Sherwin R; Winters ME; Vilke GM; Wardi G
    J Emerg Med; 2017 Oct; 53(4):588-595. PubMed ID: 28916120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic regimens for early-onset neonatal sepsis.
    Korang SK; Safi S; Nava C; Gordon A; Gupta M; Greisen G; Lausten-Thomsen U; Jakobsen JC
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013837. PubMed ID: 33998666
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.